| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/18/2006 | US20060106011 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105964 Piperazine derivatives useful as CCR5 antagonists |
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | US20060105257 Indolenine compound, near infrared absorber, and toner containing the same |
| 05/18/2006 | CA2586106A1 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
| 05/18/2006 | CA2585546A1 Indinavir derivatives useful in immunoassay |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions |
| 05/17/2006 | EP1656377A1 Aminobenzimidazole derivatives |
| 05/17/2006 | EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 05/17/2006 | EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656146A2 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1656145A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 05/17/2006 | EP1656133A2 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/17/2006 | CN1774436A Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1774265A Drug for nerve regeneration |
| 05/17/2006 | CN1256329C Herbicidal substituted benzoylpyrazoles |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045519 Pyrimidine or pyridine derivatives |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2204261C Improved method for preparing opipramol |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050162A2 Imidazole derivatives |
| 05/11/2006 | WO2006050076A1 Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| 05/11/2006 | WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006049835A2 Indole and benzimidazole derivatives |
| 05/11/2006 | WO2006049013A1 Compound containing fused ring and organic electroluminescent element employing the same |
| 05/11/2006 | WO2006048251A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/11/2006 | WO2006048237A1 Novel polymorph forms of candesartan cilexetil |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2005086892A3 Ion channel modulators |
| 05/11/2006 | WO2005065154A3 Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same |
| 05/11/2006 | US20060100437 Process for producing carbostyril derivatives |
| 05/11/2006 | US20060100425 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 05/11/2006 | US20060100260 Substituted pyrazoline carboxanilides for use as pesticides |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100228 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100226 2-Thiopyrimidinones as therapeutic agents |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | US20060100224 Piperidine ouracil used as a medicament for treating bacterial infections |
| 05/11/2006 | US20060100219 Dihydroimidazoles and tetrahydropyrmidines containing amide and sulfonamide groups, e.g., 3-[(2,3-Dichlorobenzenesulphonyl)methylamino]-N-{2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl}-N-methylpropionamide; treating pain, skin disease, irritable bladder or colon, asthma, COPD, and stomach inflammation |
| 05/11/2006 | US20060100218 Phosphodiesterase 4; asthma, chronic obstructive pulmonary disease, Alzheimer's disease, diffuse large-cell B cell lymphoma, and chronic lymphocytic leukemia; 8-[3-(3,4-dimethoxy-phenyl)-pyrrolo[2,3-b]pyridine-1-sulfonyl]-quinoline |
| 05/11/2006 | US20060100216 Novel B1 bradykinin receptor antagonists |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100208 Pyrazole derivatives as cannabinoid receptor antagonists |
| 05/11/2006 | US20060100207 Dihydropyridinone derivatives |
| 05/11/2006 | US20060100204 Anti-cytokine heterocyclic compounds |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060100191 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator |
| 05/11/2006 | US20060099638 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | CA2589106A1 Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases |
| 05/11/2006 | CA2586271A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | CA2585383A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | CA2584979A1 Indole and benzimidazole derivatives |
| 05/10/2006 | EP1656002A2 Organic light emitting device |
| 05/10/2006 | EP1655298A1 Novel polymorph forms of candesartan cilexetil |
| 05/10/2006 | EP1655295A1 Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/10/2006 | EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 05/10/2006 | EP1654255A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 05/10/2006 | EP1654254A1 Antifungal azole derivatives having a fluorovinyl moiety and process for the preparation thereof |
| 05/10/2006 | EP1654253A1 Substituted 3-pyrrolidin-indole derivatives |
| 05/10/2006 | EP1654251A1 Chemical compounds |
| 05/10/2006 | EP1654249A1 Anthelmintic and insecticide pyrimidine derivatives |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1654237A1 2-aminopyrimidine derivatives |
| 05/10/2006 | EP1654228A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653950A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 05/10/2006 | EP1653946A2 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 05/10/2006 | EP1536799B1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1140786B9 Reductive alkylation of secondary amines with hydrosilane |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |